名稱 | PD1/SHP2 Reporter Cell |
型號 | CBP74224 |
報價 | ![]() |
特點 | PD1/SHP2 Reporter Cell |
產品搜索
產品分類
相關文章
聯係我們
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區緯地路9號
Email: zhangxiangwen@cobioer.com
星空体育官方网站平台登录入口 / PRODUCTS
藥靶星空体育官方网站首页 > 腫瘤免疫星空体育官方网站首页 > CBP74224PD1/SHP2 Reporter Cell

- 詳細內容
PD1/SHP2 Reporter Cell
I. Background | |
腫瘤細胞可以借助免疫檢查點受體(ti) 逃避機體(ti) 免疫係統的識別和殺傷(shang) ,因此阻斷免疫檢 查點受體(ti) 可能是一種廣泛有效的治療方法。目前,抗 PD-1/PD-L1 抗體(ti) 雖然比較 成熟,與(yu) 抗 CTLA4 抗體(ti) 類似,但由於(yu) 存在耐藥性,患者的總體(ti) 有效率較低,因此尋找新 的治療靶點迫在眉睫。 | |
II. Background | |
PD1 SHP2 Reporter Cell 報告基因藥靶模型很好的模擬了體(ti) 內(nei) PD1/SHP2 的信號轉導過程,原理見下圖所示。
| |
III. Introduction | |
Expressed gene: | PD-1/SHP2 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+blasticidin (5ug/ml)+hygromycin (800ug/ml) |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
IV. Representative Data |
Figure 2. Recombinant PD1/SHP2 Reporter Cell constitutively expressing PD1.
Figure 3. Blocking of PD1 induced PD1 SHP2 Reporter Cell (C17) Activity by PD1 Neutralizing Antibody with PDL1 Target Cell (Suspension)(C4). Blocking of PDL1 induced PD1 SHP2 Reporter Cell (C17) Activity by Atezolizumab with PDL1 Target Cell (Suspension) (C4). Blocking of PD1 induced PD1 SHP2 Reporter Cell(C17) Activity by PD1 Neutralizing Antibody with PDL1 Target cell (Adherent)(C11). Blocking of PDL1 induced PD1 SHP2 Reporter Cell (C17) Activity by Atezolizumab with PDL1 Target Cell (Adherent)(C11).